Mechanisms of intestinal stem cell differentiation and plasticity.
Mechanisms of intestinal stem cell differentiation and plasticity.
批准号:
9788430
负责人:
NOAH Freeman SHROYER
金额:
$56.09万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2021-06-30
关键词:
AffinityBindingBinding SitesCell LineCellsChIP-on-chipChIP-seqChromatinColumnar CellComplexDown-RegulationETS DomainEnvironmentEpithelial CellsGFI1 geneGenesGenetic TranscriptionGrowth FactorHumanIn VitroInfectionInjuryIntestinesLGR5 geneLeadMeasuresMediatingMethodologyMultiprotein ComplexesMusMutationNatural regenerationNormal CellNuclearOrganoidsPaneth CellsProcessPublicationsPublishingRNARadiationRecoveryRegulationResolutionRoleSAM DomainSecretory CellSignal TransductionSpecific qualifier valueStem cellsTCF Transcription FactorTertiary Protein StructureTestingTherapeutic InterventionTranscriptional ActivationWNT Signaling Pathwayantimicrobial peptidebasebeta cateninchemotherapychromatin immunoprecipitationgut microbiomemutantnoveloverexpressionpreventprogenitorprotein complexself-renewalside effectsingle-cell RNA sequencingstem cell differentiationstem cell niche
中文摘要
潘氏细胞(PC),位于活跃的隐窝基底柱状(CBC)肠干细胞之间
肠上皮细胞(ISC)在肠道中起几种重要的稳态功能,包括i)调节肠上皮细胞的功能,
ii)作为小生境细胞提供生长因子,和
向相邻的CBC细胞发送信号。最近的证据表明,分泌细胞(注定成为PC)可以
恢复到CBC状态,以在受伤后重新填充肠道。CBC细胞高度依赖于典型的
Wnt信号传导促进增殖和自我更新。PC同样存在于高Wnt环境中,
一种强有力的细胞核β-连环蛋白,表明典型的Wnt激活--但它们不增殖。这就提出了一个
问题:有效的经典Wnt激活如何在相邻上皮细胞中产生如此不同的结果?
我们先前发表的结果确定了一个转录级联(Atoh 1-Gfi 1-SPDEF),
肠分泌细胞包括PC。我们最近的出版物表明,SPDEF(SAM指向域
ETS因子),通常在PC中表达,但在CBC中不表达,可以抑制β-连环蛋白染色质结合,
选择靶基因的转录激活。这些结果支持了我们的总体假设,即SPDEF
转移β-连环蛋白的染色质靶点以调节干细胞与潘氏细胞的命运。我们将测试这个
三个目标的假设。目的1:定义CBCs与CBCs中β-连环蛋白和SPDEF靶点的分布。
潘氏细胞。我们将使用RNA-和染色质免疫沉淀-(ChIP-)序列来定义功能性
Lgr 5 + CBC干细胞和PC中β-连环蛋白和SPDEF的靶点。这一目标将使我们的第一个纲要,
SPDEF和β-连环蛋白在肠道中的细胞特异性靶点,并测试SPDEF是否是必需的,
足以转移干细胞龛中β-连环蛋白的染色质靶点。目标2:确定
SPDEF改变β-catenin靶点转录的机制。我们将探测
SPDEF和β-catenin蛋白复合物之间的相互作用,以及转录水平的变化,
机制调控CBC与PC基因。这一目标将严格检验我们的机械假说,
SPDEF改变了β-连环蛋白的靶点,并且对于任何合理的靶向该过程的治疗是必不可少的。
干预目的3:测试SPDEF:β-连环蛋白相互作用在受损的神经再生中的作用。
地穴在这里,我们将使用单细胞RNA-seq(scRNA-seq)和ChIP来表征损伤诱导的逆转,
并确定β-连环蛋白染色质结合作为逆转过程的一部分如何变化。接下来我们就
定义下调SPDEF以实现分泌细胞逆转为
损伤后的干细胞最后,我们将使用一种新的体外损伤-逆转-再生方法,
类器官以测试SPDEF在调节β-连环蛋白指导的CBC恢复中的作用。这一目标将提供
单细胞分辨率,以确定隐窝内细胞可塑性的机制和SPDEF的作用,
再生中的β-连环蛋白/WNT信号传导。
英文摘要
Paneth cells (PCs), which reside intercalated among the active crypt base columnar (CBC) intestinal stem cells
(ISCs), serve several important homeostatic functions in the gut, including i) regulation of the intestinal
microbiome by secretion of antimicrobial peptides and ii) serving as niche cells to provide growth factors and
signals to adjacent CBC cells. Recent evidence has suggested that secretory cells (fated to become PCs) can
revert to a CBC state to repopulate the intestine following injury. CBC cells are highly dependent on canonical
Wnt signaling to drive proliferation and self-renewal. PCs likewise exist in a high-Wnt environment, and show
robust nuclear β-catenin indicative of canonical Wnt activation--but they do not proliferate. This raises the
question: how does potent canonical Wnt activation produce such different results in adjacent epithelial cells?
Our previously published results identified a transcriptional cascade (Atoh1-Gfi1-SPDEF) that specifies
intestinal secretory cells including PCs. Our recent publications indicate that SPDEF (SAM Pointed Domain
ETS Factor), which is normally expressed in PCs but not CBCs, can repress β-catenin chromatin binding and
transcriptional activation of select target genes. These results support our overarching hypothesis that SPDEF
shifts the chromatin targets of β-catenin to regulate stem cell vs. Paneth cell fate. We will test this
hypothesis in three aims. Aim 1: Define the landscape of β-catenin and SPDEF targets in CBCs vs.
Paneth cells. We will use RNA- and Chromatin Immunoprecipitation- (ChIP-) seq to define functional
targets of β-catenin and SPDEF in Lgr5+ CBC stem cells and PCs. This aim will give us the first compendium of
cell-specific targets of SPDEF and β-catenin in the intestine, and test whether SPDEF is necessary and
sufficient to shift the chromatin targets of β-catenin in the stem cell niche. Aim 2: Determine the
mechanism by which SPDEF changes transcription of β-catenin targets. We will probe the physical
interaction between SPDEF and β-catenin protein complexes, as well as the changes to transcriptional
machinery regulating CBC vs. PC genes. This aim will rigorously test our mechanistic hypothesis about how
SPDEF alters β-catenin targets, and is essential for any rational targeting of this process for therapeutic
intervention. Aim 3: Test the role for SPDEF:β-catenin interaction in regeneration of damaged
crypts. Here, we will use single-cell RNA-seq (scRNA-seq) and ChIP to characterize injury-induced reversion,
and to determine how β-catenin chromatin binding changes as part of the reversion process. Next, we will
define the requirement and sufficiency for downregulation of SPDEF to achieve reversion of secretory cells into
stem cells following injury. Finally, we will use a novel in vitro injury-reversion-regeneration methodology in
organoids to test the role for SPDEF in regulating β-catenin directed CBC recovery. This aim will provide
single-cell resolution to define the mechanism of cellular plasticity within the crypt and the role of SPDEF and
β-catenin/WNT signaling in regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
-
批准号:10454085
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2022
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
-
批准号:10632001
-
项目类别:
-
资助金额:$64.89万
-
财政年份:2022
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The Gastrointestinal Experimental Model Systems (GEMS) Core
-
批准号:10117232
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2020
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Enteroid Core
-
批准号:8855933
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2015
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Endocrine Cell Development
-
批准号:8295786
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2012
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Endocrine Cell Development
-
批准号:8456068
-
项目类别:
-
资助金额:$43.91万
-
财政年份:2012
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis.
-
批准号:8486426
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis
-
批准号:8905197
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis.
-
批准号:8294532
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis.
-
批准号:8162496
-
项目类别:
-
资助金额:$44.94万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8433478
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8033791
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:7768927
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:9093525
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8228178
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
SPDEF in intestinal differentiation.
-
批准号:7893824
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2009
-
负责人:NOAH Freeman SHROYER
-
依托单位:
SPDEF in intestinal differentiation.
-
批准号:7708206
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2009
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7342355
-
项目类别:
-
资助金额:$13.29万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7253102
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7478746
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: